annual CAPEX:
$10.70M-$4.60M(-30.06%)Summary
- As of today (June 22, 2025), HALO annual capital expenditures is $10.70 million, with the most recent change of -$4.60 million (-30.06%) on December 31, 2024.
- During the last 3 years, HALO annual CAPEX has risen by +$9.24 million (+634.11%).
- HALO annual CAPEX is now -30.06% below its all-time high of $15.29 million, reached on December 31, 2023.
Performance
HALO CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$950.00K-$2.10M(-68.87%)Summary
- As of today (June 22, 2025), HALO quarterly capital expenditures is $950.00 thousand, with the most recent change of -$2.10 million (-68.87%) on March 31, 2025.
- Over the past year, HALO quarterly CAPEX has dropped by -$2.60 million (-73.20%).
- HALO quarterly CAPEX is now -91.65% below its all-time high of $11.38 million, reached on March 31, 2023.
Performance
HALO quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$8.10M-$2.60M(-24.26%)Summary
- As of today (June 22, 2025), HALO TTM capital expenditures is $8.10 million, with the most recent change of -$2.60 million (-24.26%) on March 31, 2025.
- Over the past year, HALO TTM CAPEX has increased by +$639.00 thousand (+8.56%).
- HALO TTM CAPEX is now -48.39% below its all-time high of $15.70 million, reached on March 31, 2023.
Performance
HALO TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
HALO CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -30.1% | -73.2% | +8.6% |
| 3 y3 years | +634.1% | +93.9% | +383.1% |
| 5 y5 years | +164.8% | +733.3% | +151.0% |
HALO CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -30.1% | +634.1% | -91.7% | +158.5% | -48.4% | +383.1% |
| 5 y | 5-year | -30.1% | +634.1% | -91.7% | +158.5% | -48.4% | +460.2% |
| alltime | all time | -30.1% | +4591.2% | -91.7% | +112.1% | -48.4% | +203.5% |
HALO CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $950.00K(-68.9%) | $8.10M(-24.3%) |
| Dec 2024 | $10.70M(-30.1%) | $3.05M(+101.2%) | $10.70M(+4.5%) |
| Sep 2024 | - | $1.52M(-41.2%) | $10.24M(-12.2%) |
| Jun 2024 | - | $2.58M(-27.2%) | $11.67M(+56.4%) |
| Mar 2024 | - | $3.54M(+36.6%) | $7.46M(-51.2%) |
| Dec 2023 | $15.29M(+218.0%) | $2.60M(-11.8%) | $15.29M(+1.7%) |
| Sep 2023 | - | $2.94M(-281.4%) | $15.04M(+14.8%) |
| Jun 2023 | - | -$1.62M(-114.3%) | $13.11M(-16.5%) |
| Mar 2023 | - | $11.38M(+385.4%) | $15.70M(+226.3%) |
| Dec 2022 | $4.81M(+230.1%) | $2.34M(+132.5%) | $4.81M(+83.3%) |
| Sep 2022 | - | $1.01M(+4.1%) | $2.62M(+24.2%) |
| Jun 2022 | - | $968.00K(+97.6%) | $2.11M(+25.9%) |
| Mar 2022 | - | $490.00K(+210.1%) | $1.68M(+15.1%) |
| Dec 2021 | $1.46M(-41.8%) | $158.00K(-68.1%) | $1.46M(-51.4%) |
| Sep 2021 | - | $496.00K(-6.9%) | $3.00M(+11.9%) |
| Jun 2021 | - | $533.00K(+97.4%) | $2.68M(+0.7%) |
| Mar 2021 | - | $270.00K(-84.1%) | $2.66M(+6.2%) |
| Dec 2020 | $2.50M(-38.0%) | $1.70M(+865.3%) | $2.50M(+73.2%) |
| Sep 2020 | - | $176.00K(-65.8%) | $1.45M(-39.1%) |
| Jun 2020 | - | $515.00K(+351.8%) | $2.37M(-26.4%) |
| Mar 2020 | - | $114.00K(-82.2%) | $3.23M(-20.1%) |
| Dec 2019 | $4.04M(-13.4%) | $641.00K(-41.9%) | $4.04M(-37.6%) |
| Sep 2019 | - | $1.10M(-19.3%) | $6.47M(+13.5%) |
| Jun 2019 | - | $1.37M(+47.6%) | $5.70M(+20.0%) |
| Mar 2019 | - | $927.00K(-69.8%) | $4.75M(+1.9%) |
| Dec 2018 | $4.66M(+245.4%) | $3.07M(+822.8%) | $4.66M(+90.3%) |
| Sep 2018 | - | $333.00K(-20.3%) | $2.45M(+7.6%) |
| Jun 2018 | - | $418.00K(-50.2%) | $2.28M(+9.0%) |
| Mar 2018 | - | $839.00K(-2.4%) | $2.09M(+54.8%) |
| Dec 2017 | $1.35M(-57.0%) | $860.00K(+434.2%) | $1.35M(+44.1%) |
| Sep 2017 | - | $161.00K(-30.0%) | $937.00K(-21.9%) |
| Jun 2017 | - | $230.00K(+132.3%) | $1.20M(-43.8%) |
| Mar 2017 | - | $99.00K(-77.9%) | $2.14M(-31.9%) |
| Dec 2016 | $3.14M(+32.9%) | $447.00K(+5.4%) | $3.14M(-27.5%) |
| Sep 2016 | - | $424.00K(-63.7%) | $4.32M(+2.1%) |
| Jun 2016 | - | $1.17M(+6.2%) | $4.24M(+27.2%) |
| Mar 2016 | - | $1.10M(-32.7%) | $3.33M(+41.1%) |
| Dec 2015 | $2.36M(+72.5%) | $1.63M(+386.3%) | $2.36M(+145.3%) |
| Sep 2015 | - | $336.00K(+29.2%) | $962.00K(-3.5%) |
| Jun 2015 | - | $260.00K(+100.0%) | $997.00K(-8.3%) |
| Mar 2015 | - | $130.00K(-44.9%) | $1.09M(-20.5%) |
| Dec 2014 | $1.37M | $236.00K(-36.4%) | $1.37M(-45.1%) |
| Sep 2014 | - | $371.00K(+6.0%) | $2.49M(+1.9%) |
| Jun 2014 | - | $350.00K(-14.8%) | $2.44M(+12.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | $411.00K(-69.7%) | $2.17M(-5.4%) |
| Dec 2013 | $2.30M(+62.6%) | $1.36M(+317.8%) | $2.30M(+55.3%) |
| Sep 2013 | - | $325.00K(+306.3%) | $1.48M(+11.9%) |
| Jun 2013 | - | $80.00K(-85.0%) | $1.32M(-32.1%) |
| Mar 2013 | - | $534.00K(-1.1%) | $1.95M(+37.8%) |
| Dec 2012 | $1.41M(+70.5%) | $539.80K(+222.3%) | $1.41M(-1.2%) |
| Sep 2012 | - | $167.50K(-76.3%) | $1.43M(+9.9%) |
| Jun 2012 | - | $705.60K(+26.7%) | $1.30M(+57.1%) |
| Dec 2011 | $828.50K(+28.2%) | $557.00K(+1328.2%) | $828.50K(+37.6%) |
| Sep 2011 | - | $39.00K(+32.2%) | $602.20K(-3.5%) |
| Jun 2011 | - | $29.50K(-85.5%) | $623.80K(-10.9%) |
| Mar 2011 | - | $203.00K(-38.6%) | $700.40K(+8.4%) |
| Dec 2010 | $646.50K(-55.7%) | $330.70K(+445.7%) | $646.40K(-26.5%) |
| Sep 2010 | - | $60.60K(-42.9%) | $879.10K(-9.3%) |
| Jun 2010 | - | $106.10K(-28.8%) | $969.40K(-24.9%) |
| Mar 2010 | - | $149.00K(-73.6%) | $1.29M(-11.6%) |
| Dec 2009 | $1.46M(+26.0%) | $563.40K(+273.4%) | $1.46M(+27.0%) |
| Sep 2009 | - | $150.90K(-64.7%) | $1.15M(-19.8%) |
| Jun 2009 | - | $427.80K(+34.1%) | $1.43M(+12.6%) |
| Mar 2009 | - | $319.00K(+26.4%) | $1.27M(+9.8%) |
| Dec 2008 | $1.16M(-51.0%) | $252.40K(-42.0%) | $1.16M(-40.2%) |
| Sep 2008 | - | $435.40K(+63.1%) | $1.94M(-0.1%) |
| Jun 2008 | - | $267.00K(+30.2%) | $1.94M(-19.4%) |
| Mar 2008 | - | $205.00K(-80.2%) | $2.41M(+1.9%) |
| Dec 2007 | $2.37M(+548.4%) | $1.03M(+136.6%) | $2.37M(+64.1%) |
| Sep 2007 | - | $436.70K(-40.5%) | $1.44M(+24.2%) |
| Jun 2007 | - | $734.50K(+356.5%) | $1.16M(+138.5%) |
| Mar 2007 | - | $160.90K(+47.2%) | $486.80K(+33.4%) |
| Dec 2006 | $364.80K(+4.0%) | $109.30K(-30.0%) | $364.80K(+38.8%) |
| Sep 2006 | - | $156.20K(+158.6%) | $262.90K(+29.3%) |
| Jun 2006 | - | $60.40K(+55.3%) | $203.40K(-21.5%) |
| Mar 2006 | - | $38.90K(+425.7%) | $259.10K(-26.2%) |
| Dec 2005 | $350.90K(+53.9%) | $7400.00(-92.3%) | $350.90K(-23.6%) |
| Sep 2005 | - | $96.70K(-16.7%) | $459.00K(+18.9%) |
| Jun 2005 | - | $116.10K(-11.2%) | $386.20K(+22.0%) |
| Mar 2005 | - | $130.70K(+13.2%) | $316.60K(+38.9%) |
| Dec 2004 | $228.00K | $115.50K(+383.3%) | $227.90K(+328.4%) |
| Sep 2004 | - | $23.90K(-48.6%) | $53.20K(+21.2%) |
| Jun 2004 | - | $46.50K(+10.7%) | $43.90K(-100.6%) |
| Mar 2004 | - | $42.00K(-170.9%) | -$7.83M(>+9900.0%) |
| Dec 2003 | - | -$59.20K(-505.5%) | -$100.00(-100.2%) |
| Sep 2003 | - | $14.60K(-100.2%) | $59.10K(+32.8%) |
| Jun 2003 | - | -$7.83M(-199.4%) | $44.50K(-99.4%) |
| Mar 2003 | - | $7.87M | $7.87M |
FAQ
- What is Halozyme Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual CAPEX year-on-year change?
- What is Halozyme Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly CAPEX year-on-year change?
- What is Halozyme Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Halozyme Therapeutics?
- What is Halozyme Therapeutics TTM CAPEX year-on-year change?
What is Halozyme Therapeutics annual capital expenditures?
The current annual CAPEX of HALO is $10.70M
What is the all time high annual CAPEX for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual capital expenditures is $15.29M
What is Halozyme Therapeutics annual CAPEX year-on-year change?
Over the past year, HALO annual capital expenditures has changed by -$4.60M (-30.06%)
What is Halozyme Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of HALO is $950.00K
What is the all time high quarterly CAPEX for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly capital expenditures is $11.38M
What is Halozyme Therapeutics quarterly CAPEX year-on-year change?
Over the past year, HALO quarterly capital expenditures has changed by -$2.60M (-73.20%)
What is Halozyme Therapeutics TTM capital expenditures?
The current TTM CAPEX of HALO is $8.10M
What is the all time high TTM CAPEX for Halozyme Therapeutics?
Halozyme Therapeutics all-time high TTM capital expenditures is $15.70M
What is Halozyme Therapeutics TTM CAPEX year-on-year change?
Over the past year, HALO TTM capital expenditures has changed by +$639.00K (+8.56%)